Background DuoResp Spiromax®(Teva Pharmaceuticals) is a dry-powder inhaler designed
to deliver budesonide and formoterol fumarate (BF Spiromax®) with maximum ease of use …

Background: Wixela Inhub is a generic version of Advair Diskus recently approved by the US
Food and Drug Administration. The Inhub inhaler delivers fluticasone propionate …

Atelec Ajinomoto Hypertension JP Tablets, 20 mg; once daily. Axeron Lilly Hypogonadism
BR For testosterone replacement therapy in men for conditions associated with a deficiency …

Introduction: Patients with asthma who experience difficulty in inhaler use are less likely to
adhere to prescribed medications. Poor adherence is associated with suboptimal control …

Abstract Features the Glaxo Wellcome Inc., a pharmaceutical manufacturer. Proposed
merger between Glaxo Wellcome and SmithKline Beecham; Focus of its research and …

Introduction and objectives Asthma and COPD prevalence is rising and new treatment
options for effective and safe management of these diseases are needed. We evaluated if …

In this randomized, double-blind, placebo-controlled trial, 397 patients with moderate to
severe asthma, previously treated with bronchodilators alone, received fluticasone …

Background: A novel, inhalation-driven, multidose dry powder inhaler (MDPI) has been
developed, which allows for lower doses of fluticasone propionate (Fp) and Fp/salmeterol …

Abstract▴ Current evidence suggests that addition of the long-acting β 2-agonist salmeterol
to an inhaled corticosteroid in patients with persistent asthma symptoms provides greater …

Objective: A novel, inhalation-driven, multidose dry powder inhaler (MDPI) eliminates the
need to coordinate actuation with inhalation. To characterize dose response, efficacy, and …